STOCK TITAN

Insider Disclosure: Theis Terwey Holds 7.6% of GH Research (GHRS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Terwey Theis reports beneficial ownership of 4,692,903 ordinary shares of GH Research PLC, representing 7.6% of the outstanding class based on 62,029,395 shares outstanding as of June 30, 2025. The disclosure shows the reporting person is a German citizen and holds sole voting and sole dispositive power over all reported shares, with no shared voting or dispositive arrangements.

This Schedule 13G amendment documents a substantial ownership position above the 5% threshold that requires public disclosure; it does not specify transactions, motives, or any arrangements with other holders.

Positive

  • Beneficial ownership above 5%: 4,692,903 shares representing 7.6% of the class (material disclosure)
  • Sole voting and dispositive power over all reported shares, indicating clear, individual control of the position

Negative

  • Concentration risk: a single holder with sole voting and dispositive authority could exert outsized influence
  • No transactional detail provided, so the filing does not clarify whether the position is increasing, decreasing, or strategic

Insights

TL;DR: A disclosed 7.6% stake with sole voting and dispositive power is material but neutral absent transactional context.

Theis Terwey's 4.69 million-share holding crosses the reporting threshold and is therefore material for investors to monitor. Sole voting and dispositive authority indicates direct control over disposition and voting of these shares, which can affect shareholder votes or potential block trades. The filing contains no indication of coordinated group activity, acquisitions, or changes to the position, so the immediate market impact is informational rather than transactional.

TL;DR: Concentrated, disclosed stake with sole control raises governance relevance but provides no signal on intent.

A 7.6% ownership stake with exclusive voting and dispositive power is governance-relevant because it concentrates influence in a single holder. That concentration could shape corporate votes or strategic outcomes if exercised, yet the filing does not reveal any plans to engage with management or propose changes. Without evidence of an activist intent or coordinated group, the disclosure is a routine material ownership update.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Terwey Theis H
Signature:/s/ Theis Terwey
Name/Title:Theis Terwey
Date:08/14/2025

FAQ

Who filed the Schedule 13G/A for GH Research (GHRS)?

The Schedule 13G/A was filed by Theis Terwey, a citizen of Germany, as the reporting person.

How many GH Research (GHRS) shares does the reporting person own?

The reporting person beneficially owns 4,692,903 shares of GH Research ordinary shares.

What percentage of GH Research (GHRS) does this holding represent?

The position represents 7.6% of the outstanding ordinary shares, based on 62,029,395 shares outstanding as of June 30, 2025.

Does the filer share voting or dispositive power over these GHRS shares?

No. The filer reports sole voting power and sole dispositive power over all 4,692,903 shares and reports no shared power.

Does the filing indicate holdings on behalf of another person or a group?

No. The filing states not applicable for holdings on behalf of another person and no group membership is identified.
Gh Research Plc

NASDAQ:GHRS

View GHRS Stock Overview

GHRS Rankings

GHRS Latest News

GHRS Latest SEC Filings

GHRS Stock Data

918.66M
45.42M
Biotechnology
Healthcare
Link
Ireland
Dublin